Page last updated: 2024-10-24

bupivacaine and Craniofacial Pain Syndromes

bupivacaine has been researched along with Craniofacial Pain Syndromes in 2 studies

Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Villar-Quiles, RN1
García-Moreno, H1
Mayo, D1
Gutiérrez-Viedma, Á1
Ramos, MI1
Casas-Limón, J1
Cuadrado, ML1
Gáspár, L1

Other Studies

2 other studies available for bupivacaine and Craniofacial Pain Syndromes

ArticleYear
Infratrochlear neuralgia: A prospective series of seven patients treated with infratrochlear nerve blocks.
    Cephalalgia : an international journal of headache, 2018, Volume: 38, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anesthetics, Local; Bupivacaine; Facial Neuralgia; Female; Humans; M

2018
[Experience with the conservative management of facial neuralgia].
    Fogorvosi szemle, 1985, Volume: 78, Issue:6

    Topics: Adult; Aged; Bupivacaine; Carbamazepine; Electric Stimulation Therapy; Facial Neuralgia; Female; Hum

1985